{
    "pmcid": "11036486",
    "summary": "The paper \"Combining Rosetta Sequence Design with Protein Language Model Predictions Using Evolutionary Scale Modeling (ESM) as Restraint\" explores the integration of protein language models (PLMs) with traditional structure-based protein design methods to enhance the design of stable and functional proteins. This approach is particularly relevant for designing SARS-CoV-2 nanobody binders, where optimizing binding affinity and stability across variants is crucial.\n\n### Key Insights on ESM in Protein Design\n\n1. **Role of ESM in Protein Design**:\n   - Evolutionary Scale Modeling (ESM) is a type of protein language model that predicts the likelihood of amino acid sequences based on evolutionary data. ESM captures evolutionary dynamics and can predict the effects of mutations, which is valuable for designing proteins with enhanced stability and function.\n\n2. **Challenges in Traditional Design**:\n   - Traditional protein design using tools like Rosetta often results in sequences that are less native-like compared to natural proteins. This is because Rosetta's energy functions are primarily based on biophysical principles, which may not fully capture the evolutionary constraints present in natural sequences.\n\n3. **Combining ESM with Rosetta**:\n   - The study introduces a method to incorporate ESM predictions into Rosetta's design process. By using ESM-derived probabilities as restraints, the design process is guided towards sequences that are more likely to be stable and functional, as indicated by better PLM scores.\n\n4. **Improvement in Design Outcomes**:\n   - The integration of ESM predictions with Rosetta resulted in designed sequences that had better PLM scores, indicating a closer resemblance to native sequences. This was achieved with minimal impact on the thermodynamic stability as assessed by Rosetta's energy function.\n\n5. **Benchmarking and Validation**:\n   - The study used a benchmark of 34 de novo proteins not included in the ESM training data to validate the approach. The results showed that ESM-restrained designs had PLM scores comparable to native sequences, demonstrating the model's ability to generalize beyond its training data.\n\n6. **Implications for SARS-CoV-2 Nanobody Design**:\n   - For SARS-CoV-2 nanobody binders, the ability to predict and design sequences with high binding affinity and stability is crucial. The ESM model's capacity to predict evolutionary dynamics and guide sequence design can be particularly beneficial in optimizing nanobody interactions with viral variants.\n\n7. **Trade-offs and Complementarity**:\n   - The study highlights the trade-offs between structure-based and sequence-based design methods. While structure-based methods like Rosetta focus on achieving specific conformational states, sequence-based methods like ESM provide a broader evolutionary context, potentially leading to more functionally diverse and adaptable proteins.\n\n8. **Future Directions**:\n   - The paper suggests further exploration of ESM's application in natural protein design and experimental validation of the approach. It also points to the potential of combining PLM predictions with structure-based methods to enhance protein engineering efforts.\n\n### Conclusion\n\nThe integration of ESM with Rosetta represents a significant advancement in protein design, offering a method to create sequences that are both stable and functionally relevant. This approach is particularly promising for designing therapeutic proteins, such as SARS-CoV-2 nanobody binders, where evolutionary insights can guide the optimization of binding interactions and stability across viral variants. The study underscores the importance of combining machine learning models with traditional design tools to achieve more effective and efficient protein engineering outcomes.",
    "title": "Combining Rosetta Sequence Design with Protein Language Model Predictions Using Evolutionary Scale Modeling (ESM) as Restraint"
}